LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE) — FDA Approval ANDA202836 (SANDOZ)
LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE) — FDA Approval ANDA202836 (SANDOZ) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LISDEXAMFETAMINE DIMESYLATE; Active ingredients: LISDEXAMFETAMINE DIMESYLATE; Application number: ANDA202836.
| Brand name | LISDEXAMFETAMINE DIMESYLATE |
|---|---|
| Active ingredients | LISDEXAMFETAMINE DIMESYLATE |
| Application number | ANDA202836 |
| Sponsor | SANDOZ |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 7 |
| First approval date | 20240726 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →